Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 14/20 | 0.64 |
| ▸ | AKR1C3 | P42330 | 6/20 | 0.60 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.52 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20346373 | 0.90 | PTGS2 (0.79) | PTGS2AKR1C3HTR1APKMPTGS1 | |
| SCHEMBL20349624 | 0.88 | PTGS2 (0.83) | PTGS2AKR1C3AKR1C2HTR1APKM | |
| SCHEMBL20346375 | 0.84 | PTGS2 (0.62) | PTGS2AKR1C3AKR1C2HTR1APKM | |
| SCHEMBL13448804 | 0.83 | AKR1C3 (0.83) | PTGS2AKR1C3AKR1C2HIF1ACNR2 | |
| SCHEMBL17369628 | 0.80 | PTGS2 (0.67) | PTGS2AKR1C3AKR1C2HTR1APKM | |
| SCHEMBL25873193 | 0.80 | PTGS2 (0.80) | PTGS2AKR1C3AKR1C2HTR1APKM | |
| SCHEMBL17946351 | 0.79 | AKR1C3 (0.78) | PTGS2AKR1C3AKR1C2PTGS1GLO1 | |
| SCHEMBL4549122 | 0.78 | PTGS2 (1.00) | PTGS2AKR1C3AKR1C2HTR1APKM | |
| SCHEMBL24890591 | 0.78 | AKR1C3 (0.64) | PTGS2AKR1C3AKR1C2CNR2 | |
| SCHEMBL16557623 | 0.78 | AKR1C3 (0.71) | PTGS2AKR1C3AKR1C2PTGS1GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180186721-A1 | OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2018-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180186721-A1 | OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS | SOD1, AOC3, CBR3 | PTGS2 3910/4885AKR1C3 47/4885AKR1C2 81/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.